T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice

导出原文传递

翻译打印收藏纠错

作者： Quitt, Oliver ^[1] ; Luo, Shanshan ^[2] ; Meyer, Marten ^[3] ; Xie, Zhe ^[4] ; Golsaz-Shirazi, Forough ; Loffredo-Verde, Eva ; Festag, Julia ; Bockmann, Jan Hendrik ; Zhao, Lili ; Stadler, Daniela ; Chou, Wen-Min ; Tedjokusumo, Raindy ; Wettengel, Jochen Martin ; Ko, Chunkyu ; Noessner, Elfriede ; Bulbuc, Nadja ; Shokri, Fazel ; Luettgau, Sandra ; Heikenwaelder, Mathias ; Bohne, Felix ; Moldenhauer, Gerhard ; Momburg, Frank ; Protzer, Ulrike

作者单位： Tech Univ Munich, Sch Med, Inst Virol, Helmholtz Zent Munchen, Munich, Germany ^[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Tehran, Iran ^[2] German Canc Res Ctr, Dept Translat Immunol, Heidelberg, Germany ^[3] German Canc Res Ctr, Clin Cooperat Unit Appl Tumor Immun, Antigen Presentat & TNK Cell Activat Grp ^[4]

关键词 Viral hepatitis immunotherapy bispecific T-cell engager T-cell redirection

发布时间 2021-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交